(en) McCune et Bruch, « Progress in Pediatrics: Osteodystrophia Fibrosa », Archives of Pediatrics & Adolescent Medicine, vol. 54, no 4, , p. 806 (DOI10.1001/archpedi.1937.01980040110009)
(en) « Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases », N Engl J Med, vol. 216, no 17, , p. 727-46. (DOI10.1056/NEJM193704292161701)
(en) Estrada, Boyce, Brillante et Guthrie, « Long-term Outcomes of Letrozole Treatment for Precocious Puberty in Girls with McCune-Albright Syndrome », European Journal of Endocrinology, vol. 175, no 5, , p. 477-83. (ISSN0804-4643, PMID27562402, PMCIDPMC5066167, DOI10.1530/EJE-16-0526)
(en) Celi, Coppotelli, Chidakel et Kelly, « The Role of Type 1 and Type 2 5′-Deiodinase in the Pathophysiology of the 3,5,3′-Triiodothyronine Toxicosis of McCune-Albright Syndrome », The Journal of Clinical Endocrinology and Metabolism, vol. 93, no 6, , p. 2383–2389 (ISSN0021-972X, PMID18349068, PMCIDPMC2435649, DOI10.1210/jc.2007-2237)
(en) « Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations », J. Clin. Endocrinol. Metab., vol. 88, no 9, , p. 4413–7. (PMID12970318, DOI10.1210/jc.2002-021642, lire en ligne)
(en) Happle, « The McCune-Alrbight syndrome: a lethal gene surviving by mosaicism », Clinical Genetics, vol. 29, no 4, , p. 321–324 (DOI10.1111/j.1399-0004.1986.tb01261.x)
(en) Riminucci, Collins, Fedarko et Cherman, « FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting », Journal of Clinical Investigation, vol. 112, no 5, , p. 683–692 (ISSN0021-9738, PMID12952917, PMCIDPMC182207, DOI10.1172/JCI18399)
(en) Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, Farley FA, Molinolo AA, Bhattacharyya N, Collins MT, « Denosumab treatment for fibrous dysplasia », J Bone Miner Res, vol. 27, no 7, , p. 1462–70 (PMID22431375, PMCIDPMC3377825, DOI10.1002/jbmr.1603)
endojournals.org
jcem.endojournals.org
(en) « Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations », J. Clin. Endocrinol. Metab., vol. 88, no 9, , p. 4413–7. (PMID12970318, DOI10.1210/jc.2002-021642, lire en ligne)
issn.org
portal.issn.org
(en) Estrada, Boyce, Brillante et Guthrie, « Long-term Outcomes of Letrozole Treatment for Precocious Puberty in Girls with McCune-Albright Syndrome », European Journal of Endocrinology, vol. 175, no 5, , p. 477-83. (ISSN0804-4643, PMID27562402, PMCIDPMC5066167, DOI10.1530/EJE-16-0526)
(en) Celi, Coppotelli, Chidakel et Kelly, « The Role of Type 1 and Type 2 5′-Deiodinase in the Pathophysiology of the 3,5,3′-Triiodothyronine Toxicosis of McCune-Albright Syndrome », The Journal of Clinical Endocrinology and Metabolism, vol. 93, no 6, , p. 2383–2389 (ISSN0021-972X, PMID18349068, PMCIDPMC2435649, DOI10.1210/jc.2007-2237)
(en) Riminucci, Collins, Fedarko et Cherman, « FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting », Journal of Clinical Investigation, vol. 112, no 5, , p. 683–692 (ISSN0021-9738, PMID12952917, PMCIDPMC182207, DOI10.1172/JCI18399)
(en) Alison M Boyce et Michael T Collins, Fibrous Dysplasia/McCune-Albright Syndrome Gene Reviews, University of Washington, Seattle, (lire en ligne), « Fibrous Dysplasia/McCune-Albright Syndrome »
(en) Estrada, Boyce, Brillante et Guthrie, « Long-term Outcomes of Letrozole Treatment for Precocious Puberty in Girls with McCune-Albright Syndrome », European Journal of Endocrinology, vol. 175, no 5, , p. 477-83. (ISSN0804-4643, PMID27562402, PMCIDPMC5066167, DOI10.1530/EJE-16-0526)
(en) Celi, Coppotelli, Chidakel et Kelly, « The Role of Type 1 and Type 2 5′-Deiodinase in the Pathophysiology of the 3,5,3′-Triiodothyronine Toxicosis of McCune-Albright Syndrome », The Journal of Clinical Endocrinology and Metabolism, vol. 93, no 6, , p. 2383–2389 (ISSN0021-972X, PMID18349068, PMCIDPMC2435649, DOI10.1210/jc.2007-2237)
(en) « Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations », J. Clin. Endocrinol. Metab., vol. 88, no 9, , p. 4413–7. (PMID12970318, DOI10.1210/jc.2002-021642, lire en ligne)
(en) Riminucci, Collins, Fedarko et Cherman, « FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting », Journal of Clinical Investigation, vol. 112, no 5, , p. 683–692 (ISSN0021-9738, PMID12952917, PMCIDPMC182207, DOI10.1172/JCI18399)